Sunday, November 11, 2012 2:24:26 PM
my guess is and this is just my guess, APDN doesn't want to jump the gun with the DLA...it let's the DLA to be in the driver's seat when it comes to the PR's regarding the mandate..we know the DLA is enforcing the mandate and plans on expanding the DNA tagging requierment...after November 15 all potential bidders have to provide evidence of compliance with the DNA marking requirement...if companies want to do business with DLA they also have to do business with APDN...this is giving me confidence that PRs about contracts will come...I suspect there will be one big PR about the mandate related contracts but most likely without mentioning names and money amount..just that (for example) dozen suppliers implemented DNA tagging in their facilities and we continue to respond to new RFQs...and then will learn about financials in early December...
Recent BNBX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:09:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:14 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/25/2026 12:09:48 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/24/2026 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:06:00 PM
- BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform • Business Wire • 03/18/2026 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 09:24:23 PM
- BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers • Business Wire • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:16:58 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 07:49:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:32:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:11:07 PM
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director • Business Wire • 02/05/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 09:06:16 PM
- Digital Asset Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 01/28/2026 01:35:00 PM
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th • Business Wire • 01/27/2026 01:00:00 PM
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th • GlobeNewswire Inc. • 01/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:10:46 PM
- BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order • Business Wire • 01/05/2026 01:01:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 01:27:25 PM
